March Madness — 25% Off — Limited Time
Get All the Market Moving News, Squawk, and Mentorship NOW
get this deal
Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
March Madness — 25% Off — Limited Time
Get All the Market Moving News, Squawk, and Mentorship NOW
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Calithera Biosciences
(OTCEM:CALA)
Intraday
$0.0245
0.0045
[22.75%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0245
0.0045
[22.75%]
At close: Mar 28
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Calithera Biosciences Stock (OTC:CALA)
Calithera Biosciences Stock (OTC: CALA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 01, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Feb 1, 2023, 4:30PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Feb 1, 2023, 12:31PM
Monday, January 30, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Jan 30, 2023, 4:31PM
Friday, January 27, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Jan 27, 2023, 4:31PM
Wednesday, January 25, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Jan 25, 2023, 4:31PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Jan 25, 2023, 8:05AM
Tuesday, January 10, 2023
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Jan 10, 2023, 2:11PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jan 10, 2023, 12:31PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jan 10, 2023, 8:05AM
Why VYNE Therapeutics Shares Are Trading Higher By 82%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jan 10, 2023, 7:55AM
Monday, January 09, 2023
S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher
Lisa Levin
-
Jan 9, 2023, 2:27PM
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Jan 9, 2023, 1:42PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jan 9, 2023, 12:30PM
Nasdaq Surges Over 200 Points; Crude Oil Rises 2%
Lisa Levin
-
Jan 9, 2023, 12:07PM
Calithera Biosciences shares are trading lower after its board of directors determined to dissolve the company and liquidate its assets. Also, the company will discontinue all clinical development programs and reduce its workforce.
Michael Horton
-
Jan 9, 2023, 10:40AM
Calithera Biosciences Stock Nosedives On Complete Liquidation, Dissolution
Vandana Singh
-
Jan 9, 2023, 10:18AM
US Stocks Open Higher; Dow Rises 150 Points
Lisa Levin
-
Jan 9, 2023, 9:59AM
Calithera Biosciences Com Stk Shares To Resume Trade At 8:30 a.m. ET
Charles Gross
-
Jan 9, 2023, 8:17AM
Calithera Biosciences Announces Board Approval Of Complete Liquidation And Dissolution
Bill Haddad
-
Jan 9, 2023, 8:02AM
Calithera Biosciences Shares Halted; Pending News
Charles Gross
-
Jan 9, 2023, 7:56AM
Tuesday, November 15, 2022
Ladenburg Thalmann Downgrades Calithera Biosciences to Neutral
Benzinga Newsdesk
-
Nov 15, 2022, 7:28AM
SVB Leerink Downgrades Calithera Biosciences to Market Perform, Lowers Price Target to $2
Benzinga Newsdesk
-
Nov 15, 2022, 4:04AM
Monday, November 14, 2022
Calithera Biosciences Q3 EPS $(2.01) Misses $(1.93) Estimate
Benzinga Newsdesk
-
Nov 14, 2022, 5:42PM
Earnings Scheduled For November 14, 2022
Benzinga Insights
-
Nov 14, 2022, 5:06AM
Thursday, October 06, 2022
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Oct 6, 2022, 8:18AM
Tuesday, October 04, 2022
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Oct 4, 2022, 8:22AM
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
Lisa Levin
-
Oct 4, 2022, 3:24AM
Monday, October 03, 2022
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 3, 2022, 12:27PM
Calithera Biosciences shares are trading higher after the company announced the FDA granted Fast Track designation for sapanisertib for the treatment of NRF2-mutated squamous lung cancer.
Benzinga Newsdesk
-
Oct 3, 2022, 8:30AM
Calithera Receives FDA Fast Track Designation For Sapanisertib For Treatment Of NRF2-mutated Squamous Lung Cancer
Benzinga Newsdesk
-
Oct 3, 2022, 7:07AM
Tuesday, August 30, 2022
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
Lisa Levin
-
Aug 30, 2022, 5:23AM
Monday, August 29, 2022
This Small Cap Cancer Stock Gets An Upgrade And Price Target Bump On 'Clinical Programs Progress'
Vandana Singh
-
Aug 29, 2022, 3:52PM
Calithera Biosciences shares are trading higher after HC Wainwright & Co. upgraded the stock from Neutral to Buy and announced a price target of $8.
Benzinga Newsdesk
-
Aug 29, 2022, 2:43PM
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
Benzinga Insights
-
Aug 29, 2022, 10:11AM
HC Wainwright & Co. Upgrades Calithera Biosciences to Buy, Announces $8 Price Target
Benzinga Newsdesk
-
Aug 29, 2022, 6:11AM
Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday
Lisa Levin
-
Aug 29, 2022, 2:55AM
Friday, August 26, 2022
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Aug 26, 2022, 2:22PM
Tuesday, August 16, 2022
SVB Leerink Maintains Outperform on Calithera Biosciences, Raises Price Target to $18
Benzinga Newsdesk
-
Aug 16, 2022, 11:57AM
Monday, August 15, 2022
Calithera Biosciences Q2 Sales $3.00M, Same YoY
Benzinga Newsdesk
-
Aug 15, 2022, 4:15PM
Earnings Scheduled For August 15, 2022
Benzinga Insights
-
Aug 15, 2022, 4:30AM
Friday, August 12, 2022
Earnings Preview For Calithera Biosciences
Benzinga Insights
-
Aug 12, 2022, 10:11AM
Thursday, July 21, 2022
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
Lisa Levin
-
Jul 21, 2022, 4:40AM
Wednesday, July 20, 2022
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Jul 20, 2022, 2:02PM
Wednesday, July 13, 2022
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Jul 13, 2022, 5:38PM
Wednesday, July 06, 2022
Calithera Biosciences Announces First Patient Enrolled In Phase 2 Clinical Trial Of Sapanisertib In Relapsed/Refractory NRF2 (NFE2L2)-Mutated Squamous Non-Small Cell Lung Cancer
Bill Haddad
-
Jul 6, 2022, 4:01PM
Thursday, June 23, 2022
Calithera Commences Mid-Stage Study Of DLBCL Candidate
Ragothaman Srinivasan
-
Jun 23, 2022, 5:35PM
Calithera Biosciences Announces First Patient Enrolled In Phase 2 Clinical Trial Of Mivavotinib In Relapsed/Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Benzinga Newsdesk
-
Jun 23, 2022, 4:06PM
Thursday, June 16, 2022
27 Stocks Moving in Thursday's Pre-Market Session
Lisa Levin
-
Jun 16, 2022, 6:58AM
Wednesday, June 15, 2022
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
Vandana Singh
-
Jun 15, 2022, 8:49AM
82 Biggest Movers From Yesterday
Lisa Levin
-
Jun 15, 2022, 3:44AM
Show more